Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1975 1
1976 1
1979 1
1980 1
1982 2
1983 4
1984 2
1985 3
1987 6
1988 6
1989 5
1990 4
1991 9
1992 10
1993 11
1994 10
1995 7
1996 12
1997 14
1998 9
1999 8
2000 8
2001 4
2002 9
2003 12
2004 14
2005 6
2006 15
2007 18
2008 18
2009 18
2010 15
2011 23
2012 33
2013 30
2014 30
2015 36
2016 33
2017 32
2018 33
2019 41
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

539 results
Results by year
Filters applied: . Clear all
Page 1
The epidemiology of inflammatory bowel disease.
Burisch J, Munkholm P. Burisch J, et al. Scand J Gastroenterol. 2015 Aug;50(8):942-51. doi: 10.3109/00365521.2015.1014407. Epub 2015 Feb 17. Scand J Gastroenterol. 2015. PMID: 25687629 Review.
BACKGROUND AND AIMS: The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), are chronic relapsing disorders of unknown aetiology. ...Various subgroups carry increased risk of malignancy, e.g. those with persistent inflammation, long …
BACKGROUND AND AIMS: The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), are chronic rela …
Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess T. Sørensen JØ, et al. Liver Int. 2018 Mar;38(3):532-541. doi: 10.1111/liv.13548. Epub 2017 Sep 5. Liver Int. 2018. PMID: 28796371
BACKGROUND AND AIMS: Inflammatory bowel disease (IBD) may be complicated by primary sclerosing cholangitis (PSC). We aimed to assess the characteristics of Danish PSC-IBD patients and to compare their prognosis with IBD patients without PSC. ...Among p …
BACKGROUND AND AIMS: Inflammatory bowel disease (IBD) may be complicated by primary sclerosing cholangitis (PSC) …
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group. Weismüller TJ, et al. Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6. Gastroenterology. 2017. PMID: 28274849 Free PMC article.
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). ...Conversely, patients with ulcerative colitis had an increased risk of liver disease progression …
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflamm …
Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.
Núñez F P, Quera P R, Gomollón F. Núñez F P, et al. Gastroenterol Hepatol. 2019 May;42(5):316-325. doi: 10.1016/j.gastrohep.2019.02.004. Epub 2019 Apr 1. Gastroenterol Hepatol. 2019. PMID: 30948141 Review. English, Spanish.
The association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis should be considered a distinct clinical entity. ...
The association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis should be considered …
Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
Lee WS, Karthik SV, Ng RT, Ong SY, Ong C, Chiou FK, Wong SY, Quak SH, Aw MM. Lee WS, et al. Pediatr Neonatol. 2019 Aug;60(4):396-404. doi: 10.1016/j.pedneo.2018.09.007. Epub 2018 Oct 2. Pediatr Neonatol. 2019. PMID: 31409456 Free article.
BACKGROUND: Current knowledge on the clinical features and natural history of childhood primary sclerosing cholangitis - inflammatory bowel disease in Asia is limited. ...CONCLUSIONS: Liver disease in primary sclerosing cholangi
BACKGROUND: Current knowledge on the clinical features and natural history of childhood primary sclerosing cholangitis
The IBD and PSC Phenotypes of PSC-IBD.
Ricciuto A, Kamath BM, Griffiths AM. Ricciuto A, et al. Curr Gastroenterol Rep. 2018 Mar 28;20(4):16. doi: 10.1007/s11894-018-0620-2. Curr Gastroenterol Rep. 2018. PMID: 29594739 Review.
PURPOSE OF REVIEW: To review the characteristics of IBD and PSC that occur in association, as well as their reciprocal influences on disease evolution, in adult and pediatric populations. ...PSC occurring with Crohn's disease has been observed to be less seve …
PURPOSE OF REVIEW: To review the characteristics of IBD and PSC that occur in association, as well as their reciprocal influences on dise
Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry.
Kuo A, Gomel R, Safer R, Lindor KD, Everson GT, Bowlus CL. Kuo A, et al. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1372-1378. doi: 10.1016/j.cgh.2018.04.047. Epub 2018 Apr 26. Clin Gastroenterol Hepatol. 2019. PMID: 29705262
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is a fibrostenosing disease of the bile ducts associated with inflammatory bowel disease (IBD), for which the only treatment is liver transplantation. ...The median time of transplant-f …
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is a fibrostenosing disease of the bile ducts associ …
Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE, Conte D, Massironi S. Rossi RE, et al. Eur J Gastroenterol Hepatol. 2016 Feb;28(2):123-31. doi: 10.1097/MEG.0000000000000532. Eur J Gastroenterol Hepatol. 2016. PMID: 26636407 Review.
Primary sclerosing cholangitis (PSC) is a chronic progressive disease, usually associated with underlying inflammatory bowel diseases (IBDs), with a prevalence of 60-80% in western countries. ...A PubMed search was conducted for English-language public
Primary sclerosing cholangitis (PSC) is a chronic progressive disease, usually associated with underlying inflam
[PAPA syndrome with Crohn's disease and primary sclerosing cholangitis/autoimmune hepatitis overlap syndrome].
Schäffler H, Blattmann T, Findeisen A, Meinel FG, Meyer-Bahlburg A, Lamprecht G, Steinmüller-Magin L, Trauzeddel R, Emmert S. Schäffler H, et al. Hautarzt. 2019 Feb;70(2):116-122. doi: 10.1007/s00105-018-4312-5. Hautarzt. 2019. PMID: 30467586 German.
An association with Crohn's disease (CD), autoimmune diseases of the liver and PAPA syndrome has not yet been reported in the literature. ...The mother additionally suffered from ulcerative colitis (UC) and an overlap syndrome between autoimmune hepatitis (AIH) and …
An association with Crohn's disease (CD), autoimmune diseases of the liver and PAPA syndrome has not yet been reported in the …
Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study.
Caron B, Peyrin-Biroulet L, Pariente B, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R, Reenaers C, Serrero M, Trang-Poisson C, Nancey S, Filippi J, Abitbol V, Savoye G, Vuitton L, Viennot S, Fumery M, Reymond M, Bronowicki JP, Reimund JM, Amiot A. Caron B, et al. J Crohns Colitis. 2019 Sep 27;13(10):1239-1247. doi: 10.1093/ecco-jcc/jjz088. J Crohns Colitis. 2019. PMID: 31056693
BACKGROUND: Whether vedolizumab may be effective as a treatment for primary sclerosing cholangitis [PSC] in patients with inflammatory bowel disease [IBD] remains controversial. ...
BACKGROUND: Whether vedolizumab may be effective as a treatment for primary sclerosing cholangitis [PSC] in patients wi …
539 results
Jump to page
Feedback